EVE Investments(ASX:EVE)

EVE Investments(ASX:EVE) Company Overview

Eve Investments Limited (ASX: EVE), is a vertically integrated health and nutrition company that invests in technology start-ups that demonstrate global scalability.

The company has built a considerable market buzz around a proprietary hemp seed honey that it has been developing with unique bioactive qualities. The Meluka-branded honey is being produced by Medic Honey—which Eve Investments owns a 50% stake in—and is said to have powerful antioxidant qualities, as well as other benefits such as boosting immune defence.

Eve Investments is aiming to secure a piece of the increasingly lucrative global medical nutrition market, which is estimated to be worth $52 billion by 2022.  Research conducted by the company has shown that its' bioactive honey yields "strong immediate anti‐oxidant properties" while also displaying powerful anti‐microbial activity.